Sales of a high-tech wrap derived from sheep guts that assists in human healing is behind solid traction and profits in the United States for an ASX-listed Kiwi company.
Aroa Biosurgery made $NZ103.9 million ($84.9 million) in revenue in the year ended March 31, up 23 per cent from 2024/25, the company announced on Tuesday.